Actively Recruiting

Phase Not Applicable
Age: 18Years - 90Years
MALE
ID06147791

Risks and Benefits of Using External Scrotal Drainage in Three-piece Penile Prosthesis Implant: A Prospective Randomized Study

Led by A.O.U. Città della Salute e della Scienza · Updated on 2025-01-24

50

Participants Needed

2

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating whether using an external scrotal drainage during penile prosthetic surgery can lower the risk of post-operative complications without increasing infections in men with erectile dysfunction. This prospective randomized study involves adult male patients who have erectile dysfunction that does not respond to medication. The study aims to compare outcomes between patients receiving drainage and those who do not during penile prosthesis implantation. Participants are randomly assigned to one of two groups: Group A receives external scrotal drainage placed during surgery for 24 hours, while Group B does not receive drainage. All patients undergo implantation of a three-component penile prosthesis with antibiotic prophylaxis before and after surgery. The drainage is removed on the first post-operative day. The degree of hematoma is assessed using a standardized scale. Follow-up visits occur at 7, 15, and 30 days after surgery to monitor hematoma and surgical site infections. Additional check-ups happen monthly for the first 3 months, then every 3 months up to one year, and annually up to five years after surgery. Researchers also track the time of penile prosthesis use. The main outcome measured is the incidence of post-operative infections within one month.

CONDITIONS

Official Title

Risks and Benefits of Scrotal Drainage in Penile Prosthesis Implant

Who Can Participate

Age: 18Years - 90Years
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Written informed consent given voluntarily
  • Genetically male patient
  • Age 18 years or older
  • Having erectile dysfunction of variable or multifactorial causes
  • Erectile dysfunction not responsive to iPDE-5 medication
  • Erectile dysfunction that is unresponsive or not tolerated to treatment
Not Eligible

You will not qualify if you...

  • No signed written informed consent
  • Age younger than 18 years
  • Genetically female patient
  • Active infection in the penile or scrotal area
  • Active systemic infection
  • Immunosuppressed condition
  • Blood disorders increasing bleeding risk
  • Peyronie's Disease requiring simultaneous plaque surgery
  • Any condition that poses significant risk, confounds results, or interferes with study participation
  • Unable to participate in follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

SCDU Urologia

Torino, Torino, Italy, 10126

Not Yet Recruiting

2

A.O.U. Città della Salute e della Scienza di Torino

Turin, Turin, Italy, 10126

Actively Recruiting

Loading map...

Research Team

F

Falcone Mr Marco, Physician

P

Preto Mr Mirko, Physician

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here